LiWen Zhang

LiWen Zhang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YLYun Lu
Yun Lu
LZLu Zhou
Lu Zhou
YZYa Zou
Ya Zou
HWHua Wei
Hua Wei
YZYan Zhou
Yan Zhou
LZLiWen Zhang
LiWen Zhang
Objective: Severe cutaneous adverse reactions (SCARs) are rare but life-threatening, with antibiotics being the main cause. This retrospective study from a single center was designed to analyze the culprit drugs, clinical features and treatment outcomes of antibiotic-induced SCARs.Methods: We analyzed cases of antibiotic-induced SCARs in a tertiary hospital in China between January 2013 and January 2024, including Steven-Johnson syndrome (SJS) or Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap, toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS) and acute generalized exanthematous pustulosis (AGEP). Descriptive analysis of the demographic characteristics, clinical manifestations, treatment and prognosis were carried out.Results: Among 354 cases of SCARs, 63 validated antibiotic-related cases were included. Cephalosporins (31.7%), penicillins (25.4%), and quinolones (19.0%) were the most common triggers for SCARs. Overall, liver (50.8%), lungs (31.7%), and kidneys (23.8%) were the most frequently affected organ in SCARs cases. Eight patients (28.6%) in the SJS/SJS-TEN overlap group and 8 patients (80.0%) in the TEN group received combination therapy of corticosteroids and IVIG. Patients with SCARs caused by penicillins or cephalosporins could receive alternative treatments such as lincomamides, quinolones, and tetracyclines. The mortality rate in the TEN group was the highest at 20.0%, followed by the SJS/SJS-TEN overlap group (7.1%), and no deaths were observed in the DRESS and AGEP groups.Conclusion: The identification of the culprit antibiotics and the application of alternative antibiotic therapies are crucial for the management of antibiotic-induced SCARs. If complicated underlying conditions and complications like advanced age, cancer and pneumonia coexist with SCARs, patients might be more at risk for mortality.

1 July 2021 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
LFLi-Xin Fu
Li-Xin Fu
TCTao Chen
Tao Chen
ZGZai-Pei Guo
Zai-Pei Guo
NCNa Cao
Na Cao
LZLiWen Zhang
LiWen Zhang
PZPei-Mei Zhou
Pei-Mei Zhou
Interferon (IFN)-λ1, also named Interleukin (IL)-29, is a new member of the Type III IFN or IFN-λ family. IL-29 plays an important role in the pathogenesis of many types of autoimmune and inflammatory diseases. To study the role of IL-29 in the pathogenesis of psoriasis vulgaris. The authors detected the serum levels of IL-29 in forty-one patients with psoriasis vulgaris, twenty-three patients with atopic dermatitis and thirty-eight age and gender-matched controls by sandwich Enzyme-Linked Immunosorbent Assay (ELISA). The effects of IL-29 on the expression of cytokines, such as IL-6, IL-17, IL-8, IL-4, IL10, Interferon (IFN-γ) and Tumor Necrosis Factor-α (TNF-α), in PBMCs and HaCat cells were determined by real-time quantitative PCR. Our data indicated that serum IL-29 levels were significantly elevated in patients with psoriasis vulgaris when compared with atopic dermatitis patients and the control group. Moreover, Serum levels of IL-29 were closely associated with the severity of psoriasis vulgaris. Furthermore, IL-29 up-regulated the mRNA expression levels of IL-6, IL-17 and TNF-α in PBMCs from psoriasis vulgaris patients. In addition, IL-29 enhanced the IL-6 and IL-8 expression from the HaCat cells. This study provides the first observations on the association of IL-29 and psoriasis vulgaris and showed elevated IL-29 serum levels. The authors suggest that IL-29 may play a role in the pathogenesis of psoriasis vulgaris.

5 October 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
LZLiWen Zhang
LiWen Zhang
WWWen-Ju Wang
Wen-Ju Wang
CLCong-Hui Li
Cong-Hui Li
TCTao Chen
Tao Chen
A 46-year-female presented with a one-week history of multiple erythema and blisters with pruritus on the extremities. She had received both doses of the SARS-CoV-2 vaccine (CoronaVac developed by Sinovac Life Sciences, Beijing, China) which is an inactivated vaccine. She had no adverse reactions after the first dose.

12 November 2022 in European Journal Of Dermatology
Verified
Journal Article
Closed access
PDF file
LZLiWen Zhang
LiWen Zhang
LFLi-Xin Fu
Li-Xin Fu
HMHui-Min Meng
Hui-Min Meng
YLYong-Hong Lu
Yong-Hong Lu
TCTao Chen
Tao Chen

10 June 2022 in Skin Research and Technology
Verified
Journal Article
Open access
LZLiWen Zhang
LiWen Zhang
CLCong‐Hui Li
Cong‐Hui Li
LFLi‐Xin Fu
Li‐Xin Fu
PZPei‐Mei Zhou
Pei‐Mei Zhou
HMHui‐Min Meng
Hui‐Min Meng
TCTao Chen
Tao Chen

24 July 2022 in Skin Research and Technology
Verified
Journal Article
Open access
LZLiWen Zhang
LiWen Zhang
XSXue Shen
Xue Shen
LFLi‐Xin Fu
Li‐Xin Fu
HMHui‐Min Meng
Hui‐Min Meng
YLYong‐Hong Lu
Yong‐Hong Lu
RXRong‐Hua Xu
Rong‐Hua Xu